New
Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
Advertisement
Advertisement
ARKGvsETF 2ETF Comparison
Choose a second ETF to run a side-by-side ETF comparison with ARKG, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
ARKG performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 03/11/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | ARKG ETF 2 | -3.62%– | -10.23%– | -5.11%– | +23.23%– | -2.84%– | -70.08%– |
| Flows | ARKG ETF 2 | -$50M– | -$85M– | -$10M– | -$210M– | -$627M– | -$2.79B– |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | ARKG ETF 2 | +39.15%– | +44.62%– | +42.26%– | +45.19%– |
| Max drawdown | ARKG ETF 2 | -19.50%– | -23.94%– | -51.98%– | -80.33%– |
| Max drawdown duration | ARKG ETF 2 | 48d– | 77d– | 966d– | 1822d– |
Trading data
ARKG | ETF 2 | |
Last sale 3/13/2026 at 1:30 PM | $26.36 | – |
| Previous close 03/12/2026 | $26.17 | – |
| Consolidated volume 03/12/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Advertisement
Main metrics
Last update 3/13/2026 at 1:30 PM
Live
Closed
ARKG | ETF 2 | |
|---|---|---|
| Last price | $26.36 | – |
| 1D performance | +0.73% | – |
| AuM | $1.11 B | – |
| E/R | 0.75% | – |
Characteristics
ARKG | ETF 2 | |
|---|---|---|
| Management strategy | Active | – |
| Provider | Ark Investment | – |
| Benchmark | - | – |
| N° of holdings | 30 | – |
| Asset class | - | – |
| Trailing 12m distribution yield | Join | Join |
| Inception date | April 2, 2019 | – |
| ESG | No | – |
Advertisement
Exposure
Countries
ARKG
USA
73.95%
Switzerland
8.01%
Other
18.04%
ETF 2
Sectors
ARKG
Health Care
80.46%
Other
19.54%
ETF 2
Advertisement
Diversification
ARKG
Total weight of top 15 holdings out of 15
63.79%
ETF 2
–
Top 15 holdings
Data as of January 31, 2026
ARKG
CRISPR THERAPEUTICS
8.01%
PERSONALIS INC
6.15%
GUARDANT HEALTH INC
6.00%
10X GENOMICS INC
5.23%
BEAM THERAPEUTICS
4.81%
ILLUMINA
4.53%
NATERA
4.31%
RECURSION PHARMACEUTICALS
4.01%
CAREDX INC/D
3.44%
VERACYTE INC/D
3.29%
ADAPTIVE BIOTECHNOLOGIES
3.13%
INTELLIA THERAPEUTICS INC
3.10%
ABSCI
2.83%
IONIS PHARMACEUTICALS INC
2.62%
SCHRODINGER
2.33%
ETF 2
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
Advertisement
Latest news about ARKG
Advertisement
Advertisement
Webcast on Demand
Calamos Investments Powers the Next Phase of the Autocallable Revolution
Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.
Accepted for 1 CE Credit
